Literature DB >> 9343745

Arachidonic acid induces DNA-fragmentation in human polymorphonuclear neutrophil granulocytes.

M Köller1, P Wachtler, A Dávid, G Muhr, W König.   

Abstract

We analyzed DNA-fragmentation in human polymorphonuclear neutrophil granulocytes (PMNs) from healthy donors after addition of exogenous arachidonic acid (AA) and eicosapentaenoic acid (EPA) by flow cytometry (propidium iodide staining of DNA and DNA strand break detection). The PMNs were incubated from 30 min up to 48 hours in RPMI 1640 which was supplemented with different concentrations of AA or EPA (5-40 microM). In contrast to EPA the addition of AA led to a significant increase in apoptosis up to 67.8% compared to the RPMI-control whereas the addition of EPA led to an inhibition of DNA-fragmentation. When the cells were incubated with MK 886 (1 microM, inhibitor of leukotriene biosynthesis) an increase in DNA-fragmentation (up to 63.3%) was observed. Conversely, in the presence of indomethacin (1 microM, inhibitor of prostanoid synthesis) an inhibition in DNA-fragmentation (up to 60.9%) occurred. Furthermore, preincubation of PMNs with pentoxifylline (1mM, phosphodiesterase inhibitor) reduced AA-stimulated DNA-fragmentation up to 43.4%. These data provide evidence for the involvement of AA and distinct AA metabolites in the regulation of apoptosis in human PMNs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343745     DOI: 10.1023/a:1027326712091

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  32 in total

1.  Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis.

Authors:  R J Collins; B V Harmon; G C Gobé; J F Kerr
Journal:  Int J Radiat Biol       Date:  1992-04       Impact factor: 2.694

Review 2.  Signal transduction through lipid second messengers.

Authors:  S Spiegel; D Foster; R Kolesnick
Journal:  Curr Opin Cell Biol       Date:  1996-04       Impact factor: 8.382

Review 3.  The biochemistry of programmed cell death.

Authors:  G Kroemer; P Petit; N Zamzami; J L Vayssière; B Mignotte
Journal:  FASEB J       Date:  1995-10       Impact factor: 5.191

4.  The selective 5-lipoxygenase inhibitor A63162 reduces PC3 proliferation and initiates morphologic changes consistent with secretion.

Authors:  K M Anderson; T Seed; F Ondrey; J E Harris
Journal:  Anticancer Res       Date:  1994 Sep-Oct       Impact factor: 2.480

Review 5.  Apoptosis in leukocytes.

Authors:  M K Squier; A J Sehnert; J J Cohen
Journal:  J Leukoc Biol       Date:  1995-01       Impact factor: 4.962

Review 6.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

7.  Induction of DNA strand breaks associated with apoptosis during treatment of leukemias.

Authors:  W Gorczyca; K Bigman; A Mittelman; T Ahmed; J Gong; M R Melamed; Z Darzynkiewicz
Journal:  Leukemia       Date:  1993-05       Impact factor: 11.528

8.  Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products.

Authors:  F Colotta; F Re; N Polentarutti; S Sozzani; A Mantovani
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

9.  Glucocorticoids inhibit apoptosis of human neutrophils.

Authors:  W C Liles; D C Dale; S J Klebanoff
Journal:  Blood       Date:  1995-10-15       Impact factor: 22.113

10.  Inhibition by bacterial lipopolysaccharide of spontaneous and TNF-alpha-induced human neutrophil apoptosis in vitro.

Authors:  O Hachiya; Y Takeda; H Miyata; H Watanabe; T Yamashita; F Sendo
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

View more
  3 in total

1.  Influence of low molecular weight heparin (certoparin) and unfractionated heparin on the release of cytokines from human leukocytes.

Authors:  M Köller; F Kutscha-Lissberg; J Brom; G Weidinger; G Muhr
Journal:  Inflammation       Date:  2001-10       Impact factor: 4.092

2.  The 5-lipoxygenase-activating protein (FLAP) inhibitor, MK886, induces apoptosis independently of FLAP.

Authors:  K Datta; S S Biswal; J P Kehrer
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

3.  Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886.

Authors:  J P Kehrer; S S Biswal; E La; P Thuillier; K Datta; S M Fischer; J P Vanden Heuvel
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.